HIGHLIGHTS
- who: Methotrexate-Based Chemotherapy and colleagues from the State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China have published the paper: Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy, in the Journal: Contrast Media and Molecular Imaging 1.0 Histo-Energy Histo-Entropy 0.5 of 12/Nov/2019
- what: The aim of this study was to evaluate the prognostic value of texture features on contrast-enhanced magnetic_resonance imaging . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.